Department of Pediatrics, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Department of Hepatobiliary Surgery and Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Transpl Int. 2021 Jul;34(7):1251-1260. doi: 10.1111/tri.13872. Epub 2021 Jun 18.
Pediatric liver transplantation (PLT) has very good results at experienced transplant centers. However, there is still an ongoing discussion about inferior outcomes, especially in young infants. The aim of this retrospective study was to evaluate outcomes of infants compared to older recipients in a single center over 20 years. We conducted a retrospective study of children who received liver transplants at our center between 1991 and 2011. Only patients without other limiting organ involvement were included and compared according to age. The inclusion criteria were fulfilled by 351 patients (173 vs. 178). The most common indication in both groups was biliary atresia (82.1% vs. 49.4%). The 1-, 5-, and 10-year patient survivals were 93.8%/91.8%/91.1% and 93%/90.8%/90.1%, and the graft survivals were 90.4%/83.5%/79.6% and 89.4%/81.8%/77.5%, respectively. Complications such as postoperative bleeding, biliary complications, or perfusion impairment occurred more often in infants. Leading indications for retransplantation (vascular complications/primary nonfunction) and leading causes of death (sepsis/multiorgan failure) were the same in both groups. Significant predictors for patient loss were decade of transplantation, retransplantation, postoperative bleeding, and infections for infants. Predictors for graft loss were bowel perforation, arterial thrombosis, and age >12 months. Children can have excellent results, independent of age at PLT.
儿科肝移植(PLT)在有经验的移植中心有很好的效果。然而,对于年幼的婴儿,其结果仍存在争议。本回顾性研究的目的是在单一中心 20 多年的时间里,评估婴儿与年龄较大的受者的结果。我们对 1991 年至 2011 年期间在我院接受肝移植的儿童进行了回顾性研究。只有无其他限制器官受累的患者才被纳入,并根据年龄进行比较。351 名患者符合纳入标准(173 名 vs. 178 名)。两组最常见的适应证均为胆道闭锁(82.1% vs. 49.4%)。两组患者的 1、5、10 年存活率分别为 93.8%/91.8%/91.1%和 93%/90.8%/90.1%,移植物存活率分别为 90.4%/83.5%/79.6%和 89.4%/81.8%/77.5%。婴儿术后出血、胆道并发症或灌注损伤等并发症更为常见。再次移植的主要适应证(血管并发症/原发性无功能)和死亡的主要原因(败血症/多器官衰竭)在两组中相同。影响患者生存率的显著因素为移植年代、再次移植、术后出血和感染。影响移植物存活率的因素为肠穿孔、动脉血栓形成和年龄>12 个月。儿童在接受 PLT 时无论年龄大小,都可以获得良好的效果。